130 related articles for article (PubMed ID: 33459498)
1. Endocannabinoids increase human adipose stem cell differentiation and growth factor secretion in vitro.
Ruhl T; Schneider PA; Kim BS; Beier JP
J Tissue Eng Regen Med; 2021 Jan; 15(1):88-98. PubMed ID: 33459498
[TBL] [Abstract][Full Text] [Related]
2. The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation.
Smith M; Wilson R; O'Brien S; Tufarelli C; Anderson SI; O'Sullivan SE
PLoS One; 2015; 10(9):e0136546. PubMed ID: 26414859
[TBL] [Abstract][Full Text] [Related]
3. GPR55 inhibits the pro-adipogenic activity of anandamide in human adipose stromal cells.
Ruhl T; Nuptybayeva A; Kim BS; Beier JP
Exp Cell Res; 2024 Feb; 435(1):113908. PubMed ID: 38163565
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study.
Ruhl T; Corsten C; Beier JP; Kim BS
Pharmacol Rep; 2021 Feb; 73(1):143-153. PubMed ID: 33026642
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids and inflammatory response in periodontal ligament cells.
Özdemir B; Shi B; Bantleon HP; Moritz A; Rausch-Fan X; Andrukhov O
PLoS One; 2014; 9(9):e107407. PubMed ID: 25226300
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.
Krishnan G; Chatterjee N
Glia; 2012 Nov; 60(11):1629-45. PubMed ID: 22807196
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis.
Chianese R; Ciaramella V; Fasano S; Pierantoni R; Meccariello R
Gen Comp Endocrinol; 2014 Sep; 205():88-93. PubMed ID: 24566122
[TBL] [Abstract][Full Text] [Related]
8. Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol.
Catani MV; Fezza F; Baldassarri S; Gasperi V; Bertoni A; Pasquariello N; Finazzi-Agrò A; Sinigaglia F; Avigliano L; Maccarrone M
J Mol Med (Berl); 2009 Jan; 87(1):65-74. PubMed ID: 18820887
[TBL] [Abstract][Full Text] [Related]
9. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
10. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells.
Opitz CA; Rimmerman N; Zhang Y; Mead LE; Yoder MC; Ingram DA; Walker JM; Rehman J
FEBS Lett; 2007 Oct; 581(25):4927-31. PubMed ID: 17904123
[TBL] [Abstract][Full Text] [Related]
11. The effect of hypergravity, hyperbaric pressure, and hypoxia on osteogenic differentiation of adipose stem cells.
Lingens LF; Ruhl T; Beier JP; Mende W; Freund G; Götzl R
Tissue Cell; 2022 Oct; 78():101886. PubMed ID: 35985248
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid anandamide impairs in vitro decidualization of human cells.
Almada M; Amaral C; Diniz-da-Costa M; Correia-da-Silva G; Teixeira NA; Fonseca BM
Reproduction; 2016 Oct; 152(4):351-61. PubMed ID: 27568210
[TBL] [Abstract][Full Text] [Related]
13. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.
Cencioni MT; Chiurchiù V; Catanzaro G; Borsellino G; Bernardi G; Battistini L; Maccarrone M
PLoS One; 2010 Jan; 5(1):e8688. PubMed ID: 20098669
[TBL] [Abstract][Full Text] [Related]
14. Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation.
Köse S; Aerts-Kaya F; Köprü ÇZ; Nemutlu E; Kuşkonmaz B; Karaosmanoğlu B; Taşkıran EZ; Altun B; Uçkan Çetinkaya D; Korkusuz P
Exp Hematol; 2018 Jan; 57():30-41.e1. PubMed ID: 29030083
[TBL] [Abstract][Full Text] [Related]
15. Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation.
Karaliota S; Siafaka-Kapadai A; Gontinou C; Psarra K; Mavri-Vavayanni M
Obesity (Silver Spring); 2009 Oct; 17(10):1830-8. PubMed ID: 19543211
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species.
Park SW; Kim JE; Oh SM; Cha WJ; Hah JH; Sung MW
Head Neck; 2015 Aug; 37(8):1187-92. PubMed ID: 24797795
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of FAAH confers increased stem cell migration via PPARα.
Wollank Y; Ramer R; Ivanov I; Salamon A; Peters K; Hinz B
J Lipid Res; 2015 Oct; 56(10):1947-60. PubMed ID: 26263913
[TBL] [Abstract][Full Text] [Related]
19. Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.
Chiurchiù V; Rapino C; Talamonti E; Leuti A; Lanuti M; Gueniche A; Jourdain R; Breton L; Maccarrone M
J Immunol; 2016 Nov; 197(9):3545-3553. PubMed ID: 27694494
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
